Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies

Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies

Bibliographic Details
Main Authors:	Noppacharn Uaprasert, Sasinipa Trithiphen, Autcharaporn Sukperm, Benjaporn Akkawat, Phandee Watanaboonyongcharoen, Rattaporn Vichitratchaneekorn, Thanisa Tongbai, Watsamon Jantarabenjakul, Leilani Paitoonpong, Ponlapat Rojnuckarin
Format:	Article
Language:	English
Published:	Elsevier 2021-12-01
Series:	Research and Practice in Thrombosis and Haemostasis
Online Access:	https://doi.org/10.1002/rth2.12625

Similar Items

Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination
by: Noppacharn Uaprasert, et al.
Published: (2021-08-01)

Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
by: Thiti Asawapanumas, et al.
Published: (2022-01-01)

Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
by: Noppacharn Uaprasert, et al.
Published: (2022-12-01)

Antiplatelet activity of deferiprone through cyclooxygenase-1 inhibition
by: Ngan Thi Tran, et al.
Published: (2020-05-01)

Durability of ChAdOx1 nCov-19 vaccination in people living with HIV
by: Ogbe, A, et al.
Published: (2022)

Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine
by: Lea Krutzke, et al.
Published: (2022-07-01)

LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination
by: Tamara Garibashvili, et al.
Published: (2022-06-01)

Long-term immunogenicity in previously vaccinated healthcare workers with inactivated virus vaccine after SARS-CoV-2 infection or booster vaccination
by: Varalee Terbsiri, et al.
Published: (2023-08-01)

DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination
by: Gerardo Casucci, et al.
Published: (2021-06-01)

AZD1222 (ChAdOx1 nCoV-19) Vaccine: Hurdles and Visions
by: Md. Altamash Ahmad, et al.
Published: (2023-03-01)

ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - author's reply
by: Voysey, M, et al.
Published: (2021)

Chronic Inflammatory Demyelinating Polyneuropathy after ChAdOx1 nCoV-19 Vaccination
by: Caterina Francesca Bagella, et al.
Published: (2021-12-01)

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
by: Jer-Hwa Chang, et al.
Published: (2022-02-01)

Effectiveness of the chAdOx1 nCoV-19 vaccine in preventing COVID-19 infection
by: Tarana Sarwat, et al.
Published: (2022-01-01)

An autopsy case of cerebral arterial thrombosis after vaccination with ChAdOx1 nCOV-19
by: Hyeji Yang, et al.
Published: (2022-08-01)

Myocardial infarction after ChAdOx1 nCoV-19 in a young male
by: V V. S. S. Sagar, et al.
Published: (2022-01-01)

Erythrodermic psoriasis following ChAdOx1 nCOV-19 vaccination: A case report
by: Pei-Tzu Lin, et al.
Published: (2022-01-01)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply
by: Voysey, M, et al.
Published: (2020)

Association of Reactogenicity with Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Hemodialysis
by: Ting-Yun Lin, et al.
Published: (2022-08-01)

Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
by: Nawamin Pinpathomrat, et al.
Published: (2022-05-01)

Thrombotic thrombocytopenic purpura following ChAdOx1 nCov-19 vaccination: A case report
by: Bahareh Shateri Amiri, et al.
Published: (2023-01-01)

Vaccine‐induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV‐19 is rare in Asia
by: Kochawan Boonyawat, et al.
Published: (2022-01-01)

Covid Antibody Titers in Cancer Patients Following Vaccination with ChAdOx1 nCOV-19 Vaccine
by: Ashish Chavan, et al.

Alopecia areata following ChAdOx1 nCoV-19 vaccination (Oxford/AstraZeneca)
by: Hsuan-An Su, et al.
Published: (2022-10-01)

Fatal myositis, rhabdomyolysis and compartment syndrome after ChAdOx1 nCoV-19 vaccination
by: Szu-Ting Huang, et al.
Published: (2022-12-01)

Accelerated hypertension and intracerebral haemorrhage following first dose of ChAdOx1-nCOV-19 vaccination
by: Shweta Pandey, et al.
Published: (2022-01-01)

Sarcoidosis presenting as bilateral optic neuritis after ChAdOx1 nCoV-19 vaccination
by: Amarendra Kumar Shukla, et al.
Published: (2022-06-01)

PB2536: ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE PREMEDICATION IN PATIENTS WITH CHRONIC TRANSFUSION: A PROSPECTIVE, RANDOMIZED CONTROLLED TRIAL
by: Supanat Janyangam, et al.
Published: (2023-08-01)

Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report
by: Porntip Intapiboon, et al.
Published: (2023-02-01)

ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply
by: Madhi, SA, et al.
Published: (2021)

Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report
by: Tan, Wee Yong, et al.
Published: (2021)

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
by: Marchevsky, NG, et al.
Published: (2022)

Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination
by: Hillson, K, et al.
Published: (2021)

ChAdOx1 nCoV-19 Vaccine Side Effects among Healthcare Workers in Trinidad and Tobago
by: Chavin D. Gopaul, et al.
Published: (2022-03-01)

Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
by: Jinnam Kim, et al.
Published: (2023-04-01)

Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States
by: Abanoub Riad, et al.
Published: (2021-06-01)

Antibody Response to ChAdOx1 nCoV-19 (AZD1222) Vaccine in Kidney Transplant Recipients
by: Dharmendra S. Bhadauria, et al.
Published: (2022-10-01)

A Review on Suggested Mechanisms in Thrombocytopenia and Thrombosis Following ChAdOx1 nCoV-19 Vaccination
by: Negar Mottaghi Dastgerdi, et al.
Published: (2021-11-01)

Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis.
by: I-Ning Yang, et al.
Published: (2022-01-01)

Acute rejection post-ChAdOx1 nCoV-19 vaccine in a kidney-transplant recipient
by: Karthikeyan Manoharan, et al.
Published: (2022-01-01)